期刊文献+

改良人源杀菌肽LL-37的两种构建及表达方法的对比研究

Comparison of 2 kinds of construction and expression methods of reconstructed human cathelicidin LL-37
在线阅读 下载PDF
导出
摘要 目的将改良人源杀菌肽LL-37(rLL-37)用两种方法构建,并分别在原核细胞中融合表达,以寻找较好的制备方法。方法①将编码rLL-37基因序列放入载体pET-28a(+),构建表达质粒pET-28a(+)-rLL-37,并于工程菌BL21(DE3)中融合表达、纯化;②将编码rLL-37基因序列中的部分原核细菌稀有密码子替换为原核细菌偏爱密码子,并在其N端加入一段编码带负电荷的承载蛋白(carrierproteinmolecule,CPM)基因序列,构建表达质粒pET-30a(+)-CPM-rLL-37,并于工程菌BL21Star(DE3)中融合表达、纯化。对比上述2种方法rLL-37的制备率,并初步研究其抗菌性。结果通过Touch-DownPCR法成功获得rLL-37多肽的DNA序列,质粒pET-28a(+)-rLL-37于杆菌BL21(DE3)中表达,融合蛋白约占全菌蛋白的20%,并成功由强阳离子交换柱芯Macro-PrepHighS纯化;设计了一段含28个氨基酸残基的CPM(pHi2.7、pH7.4时电荷为-6.0),成功构建表达质粒pET-30a(+)-CPM-rLL-37,并于杆菌BL21star(DE3)中表达,融合蛋白约占全菌蛋白的35%,并被TALON亲和柱芯有效纯化。经抑菌圈实验证明两种方法所获得的rLL-37多肽对G+、G-菌都具有较好的杀菌力。结论rLL-37在原核细胞中的高效表达,为深入研究rLL-37的杀菌活性奠定了基础。 Objective To employ 2 approaches to construct and express reconstructed LL-37 (rLL-37) in procaryotic system, and to explore a better preparation method. Methods The first method: the rLL-37 was inserted into vector pET-28a ( + ) , then was induced to express in E. coll. BL21 ( DE3 ) and purified by chromatography; the second method: the rare codons in the rLL-37 gene sequence were substituted by the preferred codons of procaryotic cell, and a fragment of carrier protein molecule (CPM) was added to the N termination of the objective sequence to construct expression plasmid pET-30a( + )-CPM-rLL-37, then the rLL-37 was expressed in E. coli. BL21 Star ( DE3 ) and purified by chromatography. The productive rates of the 2 methods were compared and the antimicrobial effects of obtained rLL-37 was studied. Results The first method: the DNA sequence of rLL-37 was obtained successively by Touch-Down PCR. The expression plasmid pET-30a (+)-CPM-rLL-37 was expressed with fusion protein in E. coli BL21 (DE3). The expression rate accounted for 20% of total bacterio-protein, then the expressed product was purified by using high positive ion exchange column Macro-Prep High S; The second method: a fragment of carrier protein molecule was designed that contained 28 amino-acid residue and its pHi was 2.7, net charge was - 6.0 at pH 7.4. After the expression plasmid pET-30a( + )-CPM-rLL-37 was constructed successively, it was expressed in E. coli BL21 Star (DE3). The expressed fusion protein accounted for 35% of total bacterio-protein, then the expressed product was purified by using affinity binding chromatography with TALON resins successfully. The obtained 2 kinds of rLL-37 were able to kill both Gram-negative and-positive bacteria by the means of inhibitory zone. Conclusion It's feasible to prepare efficiently rLL-37 in procaryotic system, which founds the basis for the further research on bactericidal activity of rLL-37.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2006年第20期2020-2023,共4页 Journal of Third Military Medical University
基金 国家自然科学基金资助项目(30400426) 西南医院创新基金资助项目(2002)~~
关键词 LL-37 蛋白质融合表达 承载蛋白 human cathelicidin LL-37 expression of fusion protein carrier protein molecule
  • 相关文献

参考文献9

  • 1ZANETTI M.Cathelicidins,multifunctional peptides of the innate immunity[J].Leukoc Biol 2004,75(1):39-48.
  • 2SCOTT M G,DAVIDSON D J,GOLD M R,et al.The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses[J].J Immunol,2002,169(7):3883.
  • 3NAGAOKA I,HIROTA S,NIYONSABA F,et al.Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues[J].Clin Diagn Lab Immunol,2002,9(5):972-982.
  • 4NAGAOKA I,KUWAHARA-ARAI K,TAMURA H,et al.Augmentation of the bactericidal activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by amino acid substitutions[J].Inflamm Res,2005,54(2):66-73.
  • 5葛晓冬,刘友生,杨艳丽,邹佳.人源LL-37杀菌多肽的改建及原核细胞中表达[J].第三军医大学学报,2006,28(7):636-639. 被引量:4
  • 6NELL M,TJABRINGA G,WAFELMAN A,et al.Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application[J].Peptides,2005,27(4):649-660.
  • 7饶贤才,金晓琳,胡晓梅,朱军民,陈自瑾,胡福泉.一个承载分子的设计与肽抗生素hPAB-β的高效表达[J].第三军医大学学报,2002,24(4):389-392. 被引量:11
  • 8袁榴娣,窦非,梁玉璞,谢维,王芳,张双全,戴祝英.含有FXa切割位点的抗菌肽X在大肠杆菌中的融合表达[J].生物工程学报,2000,16(3):411-414. 被引量:5
  • 9ZHAO C,NGUYEN T,BOO L M,et al.RL-37,an alpha-helical antimicrobial peptide of the rhesus monkey[J].Antimicrob Agents Chemother,2001,45(10):2695-2702.

二级参考文献12

  • 1谢维,邱奇峰,陈江宁,马忠,徐贤秀.中国家蚕抗菌肽CMIV基因的合成与克隆[J].南京大学学报(自然科学版),1996,32(3):474-478. 被引量:5
  • 2HANCOCK R E,DIAMOND G.The role of cationic antimicrobial peptides in innate host defences[J].Trends Microbiol,2000,8 (9):402-410.
  • 3LEHRER R I,GANZ T.Cathelicidins:a family of endogenous antimicrobial peptides[J].Curr Opin Hematol,2002,9 (1):18 -22.
  • 4HASE K,ECKMANN L,LEOPARD J D,et al.Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium[J].Infect Immun,2002,70(2):953 -963.
  • 5NIYONSABA F,IWABUCHI K,SOMEYA A,et al.A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis[J].Immunology,2002,106(1):20-26.
  • 6NIZET V,OHTAKE T,LAUTH X,et al.Innate antimicrobial peptide protects the skin from invasive bacterial infection[J].Nature,2001,414(6862):454 -457.
  • 7NAGAOKA I,KUWAHARA-ARAI K,TAMURA H,et al.Augmentation of the bactericidal activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by amino acid substitutions[J].Inflamm Res,2005,54(2):66 -73.
  • 8BOWDISH D M,DAVIDSON D J,SCOTT M G,et al.Immunomodulatory activities of small host defense peptides[J].Antimicrob Agents Chemother,2005,49(5):1727-1732.
  • 9HASE K,MURAKAMI M,IIMURA M,et al.Expression of LL-37by human gastric epithelial cells as a potential host defense mechanism against Helicobacter pylori[J].Gastroenterology,2003,125 (6):1613-1625.
  • 10SCHALLER-BALS S,SCHULZE A,BALS R.Increased levels of antimicrobial peptides in tracheal aspirates of newborn infants during infection[J].Am J Respir Crit Care Med,2002,165(7):992 -995.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部